F. Hoffmann-La Roche AG
Explore F. Hoffmann-La Roche
Core profile pages, annual revenue records, and related research hubs for this company.
F. Hoffmann-La Roche AG
Explore F. Hoffmann-La Roche
Core profile pages, annual revenue records, and related research hubs for this company.
Business Model Analysis
Annual Revenue: $77.19B
Roche makes money from branded prescription medicines, biologics, oncology and specialty drugs, diagnostic instruments, diagnostic reagents, sequencing and molecular testing, diabetes care products, and clinical data assets. Pharmaceuticals drive the largest share of sales, while Diagnostics adds recurring reagent revenue and supports personalized healthcare.
Roche is investing in late-stage medicines, diagnostics platforms, sequencing, companion diagnostics, real-world evidence, and selective acquisitions that strengthen oncology, immunology, neuroscience, and cardiovascular-metabolic disease areas.